Book a demo

Chemical intelligence powered by cypris.ai

(3S,5R)-3-(dimethylamino)-1,5-dihydroxyhexan-2-one

(3S,5R)-3-(dimethylamino)-1,5-dihydroxyhexan-2-one

FormulaC8H17NO3
Mol. weight175.228
PubChem CID57091830
InChIKeyHWTLJGBYQAPJOF-RQJHMYQMSA-N
SMILESC[C@H](C[C@@H](C(=O)CO)N(C)C)O
357Patents
55Research papers
0Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Kosan Biosciences Inc45
2Pfizer Inc33
3Pfizer Corp SRL25
4Abbott Laboratories24
5Fidelta doo21
6Melinta Subsidiary Corp15
7Beecham Group PLC12
8Pfizer Corp Belgium12
9Merck Sharp & Dohme LLC11
10Leland Stanford Junior University10

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1C07HSugars and derivatives236
2A61PTherapeutic activity (drug indications)214
3A61KMedicinal preparations97
4C12NMicroorganisms, enzymes85
5C07DHeterocyclic compounds81
6C12PFermentation, enzyme processes77
7C07KPeptides23
8Y02PClimate change mitigation: production23
9C40B14
10Y02AClimate change adaptation11

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Microbial Natural Products and Biosynthesis1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Hung‐wen LiuThe University of Texas at Austin10
2Lishan ZhaoUniversity of Minnesota4
3Clelia PeanoNational Research Council3
4David H. ShermanUniversity of Michigan3
5E. Sethe BurgieUniversity of Wisconsin–Madison3
6Gianluca De BellisNational Research Council3
7Giorgio CortiNational Research Council3
8Hazel M. HoldenUniversity of Wisconsin–Madison3
9Mark W. RuszczyckyThe University of Texas at Austin3
10Shengying LiUniversity of Michigan3

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of this compound?

The compound has a molecular formula of C8H17NO3 and a molecular weight of 175.228 g/mol.

Which organizations hold the most patents related to this compound?

Kosan Biosciences Inc holds the most patents with 45, followed by Pfizer Inc with 33 patents, and Pfizer Corp SRL with 25 patents.

Who are the most prolific authors publishing on this compound?

Hung‐wen Liu from The University of Texas at Austin has published the most papers on this compound with 10 papers. Other active researchers include Lishan Zhao from University of Minnesota with 4 papers.

What research topics are associated with this compound's scientific literature?

The research topics include Microbial Natural Products and Biosynthesis, Pharmaceutical and Antibiotic Environmental Impacts, Carbohydrate Chemistry and Synthesis, and Pneumonia and Respiratory Infections.

What patent classifications dominate the intellectual property landscape for this compound?

The most common patent classifications are C07H (Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids) with 236 patents, A61P (Specific therapeutic activity of chemical compounds or medicinal preparations) with 214 patents, and A61K (Preparations for medical, dental, or toilet purposes) with 97 patents.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial